tiprankstipranks

GB:CURE Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
16Bullish
1Neutral
5Bearish
Oscillators
Sell
4Bullish
1Neutral
5Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.19, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 19.79, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 19.69, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Jan 31, 2025, 12:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.16
20.16
20.16
20.16
20.16
20.16
20.16
Fibonacci
20.16
20.16
20.16
20.16
20.16
20.16
20.16

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Jan 31, 2025, 12:41 PM
Period
Simple
Exponential
MA5
20.25Buy
20.20Buy
MA10
19.93Buy
19.99Buy
MA20
19.63Buy
19.79Buy
MA50
19.71Buy
19.69Buy
MA100
19.73Buy
19.66Buy
MA200
19.49Buy
19.52Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 19.99, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 19.66, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 19.71, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 19.73, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.49, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Jan 31, 2025, 12:41 PM
Name
Value
Action
RSI (14)
64.44
Neutral
STOCH (9,6)
96.06
Sell
STOCHRSI (14)
96.93
Sell
MACD (12,26)
0.19
Sell
ADX (14)
16.44
Buy
Williams %R
-0.33
Sell
CCI (14)
141.80
Sell
ATR (14)
0.18
-
Ultimate Oscillator
93.05
Buy
ROC
6.25
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 64.44, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 16.44, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 141.80, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 6.25, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 64.44, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.19, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 20.25, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 19.63, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 19.71, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.49, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -0.33, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 141.80, which suggests CURE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis